Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinya Sato

Showing results (481-490 of 514) with videos related to

Pageof 52
Sort By:
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|June 10, 2020
Thyroid-stimulating hormone is an independent risk factor of non-alcoholic fatty liver diseaseKazuki Tahara, Takemi Akahane, Tadashi Namisaki, et al.
Journal of Clinical Medicine|November 3, 2020
Accuracy of Fibrosis-4 Index in Identification of Patients with Cirrhosis Who Could Potentially Avoid Variceal Screening EndoscopyKoji Ishida, Tadashi Namisaki, Koji Murata, et al.
In Vivo (Athens, Greece)|July 2, 2020
Clinicopathological Features in Elderly ALK-rearranged Non-small Cell Lung Cancer PatientsKunihiko Miyazaki, Shinya Sato, Takahide Kodama, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Hemoglobin and Endotoxin Levels Predict Sarcopenia Occurrence in Patients with Alcoholic CirrhosisAkihiko Shibamoto, Tadashi Namisaki, Junya Suzuki, et al.
Cancer Research|August 22, 2019
Pathogenic Epigenetic Consequences of Genetic Alterations in IDH-Wild-Type Diffuse Astrocytic GliomasFumiharu Ohka, Keiko Shinjo, Shoichi Deguchi, et al.
International Journal of Molecular Sciences|March 13, 2024
ADAMTS-13: A Prognostic Biomarker for Portal Vein Thrombosis in Japanese Patients with Liver CirrhosisJunya Suzuki, Tadashi Namisaki, Hiroaki Takya, et al.
Hepatology Communications|February 7, 2018
Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on hepatic fibrosisTadashi Namisaki, Kei Moriya, Mitsuteru Kitade, et al.
Plos One|October 15, 2015
New Insights into Plagiogrammaceae (Bacillariophyta) Based on Multigene Phylogenies and Morphological Characteristics with the Description of a New Genus and Three New SpeciesChun L Li, Matt P Ashworth, Andrzej Witkowski, et al.
Internal Medicine (Tokyo, Japan)|July 23, 2019
Gastric Perforation due to Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder during the Treatment of Rheumatoid ArthritisShiho Toyama, Ayuko Takatani, Tomohiro Koga, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 11, 2018
Proton pump inhibitor therapy does not increase serum endotoxin activity in patients with cirrhosisYasushi Okura, Tadashi Namisaki, Shinya Sato, et al.
Pageof 52

Showing results (481-490 of 514) with videos related to

Sort By:
Pageof 52
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|June 10, 2020
Thyroid-stimulating hormone is an independent risk factor of non-alcoholic fatty liver diseaseKazuki Tahara, Takemi Akahane, Tadashi Namisaki, et al.
Journal of Clinical Medicine|November 3, 2020
Accuracy of Fibrosis-4 Index in Identification of Patients with Cirrhosis Who Could Potentially Avoid Variceal Screening EndoscopyKoji Ishida, Tadashi Namisaki, Koji Murata, et al.
In Vivo (Athens, Greece)|July 2, 2020
Clinicopathological Features in Elderly ALK-rearranged Non-small Cell Lung Cancer PatientsKunihiko Miyazaki, Shinya Sato, Takahide Kodama, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Hemoglobin and Endotoxin Levels Predict Sarcopenia Occurrence in Patients with Alcoholic CirrhosisAkihiko Shibamoto, Tadashi Namisaki, Junya Suzuki, et al.
Cancer Research|August 22, 2019
Pathogenic Epigenetic Consequences of Genetic Alterations in IDH-Wild-Type Diffuse Astrocytic GliomasFumiharu Ohka, Keiko Shinjo, Shoichi Deguchi, et al.
International Journal of Molecular Sciences|March 13, 2024
ADAMTS-13: A Prognostic Biomarker for Portal Vein Thrombosis in Japanese Patients with Liver CirrhosisJunya Suzuki, Tadashi Namisaki, Hiroaki Takya, et al.
Hepatology Communications|February 7, 2018
Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on hepatic fibrosisTadashi Namisaki, Kei Moriya, Mitsuteru Kitade, et al.
Plos One|October 15, 2015
New Insights into Plagiogrammaceae (Bacillariophyta) Based on Multigene Phylogenies and Morphological Characteristics with the Description of a New Genus and Three New SpeciesChun L Li, Matt P Ashworth, Andrzej Witkowski, et al.
Internal Medicine (Tokyo, Japan)|July 23, 2019
Gastric Perforation due to Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder during the Treatment of Rheumatoid ArthritisShiho Toyama, Ayuko Takatani, Tomohiro Koga, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 11, 2018
Proton pump inhibitor therapy does not increase serum endotoxin activity in patients with cirrhosisYasushi Okura, Tadashi Namisaki, Shinya Sato, et al.
Pageof 52